| [1] | Wei GUO, Xin LI, Mingda WANG, Tian YANG. Recommendations from Annals of Surgical Oncology： Clinical guidelines for extrahepatic cholangiocarcinoma and gallbladder carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(4): 682-687. doi: 10.12449/JCH240407 |
| [2] | Bohua ZHANG, Yan XU, Song ZHANG, Hua HU. Expression of CXCL10 and CXCL12 in gallbladder carcinoma and their mechanism of action in tumor invasion[J]. Journal of Clinical Hepatology, 2024, 40(11): 2260-2265. doi: 10.12449/JCH241120 |
| [3] | Zhang CongQi, Wu Hao, Xing MingXuan, Wang Wu. Mixed adenoneuroendocrine carcinoma of the gallbladder with hepatic metastasis: A case report[J]. Journal of Clinical Hepatology, 2020, 36(3): 657-658. doi: 10.3969/j.issn.1001-5256.2020.03.039 |
| [4] | Liu Yan, Wang Yong, Li Ming. Primary undifferentiated polymorphic sarcoma in gallbladder: a report of one case [J]. Journal of Clinical Hepatology, 2014, 30(3): 276-277. doi: 10.3969/j.issn.1001-5256.2014.03.020 |
| [5] | Jiang Han, Wang ZiHao, Li YongSheng, Bian Rui, Shi WeiBin. Anti-gallbladder carcinoma activity of a novel nano-drug delivery system based on 3D cell culture model [J]. Journal of Clinical Hepatology, 2014, 30(3): 264-268. doi: 10.3969/j.issn.1001-5256.2014.03.017 |
| [6] | Shi JingSen, Zheng JianBao. Further improvement in overall level of diagnosis and treatment of gallbladder cancer[J]. Journal of Clinical Hepatology, 2013, 29(6): 401-403. |
| [7] | Wei JianWen, Lin FangPing. Experience in diagnosis and treatment of 16 cases of Mirizzi syndrome[J]. Journal of Clinical Hepatology, 2012, 28(7): 513-515. |
| [8] | Shi JingSen, Zheng JianBao, Li ZongFang, Sun XueJun. Surgical management of gallbladder cancer: Key issues[J]. Journal of Clinical Hepatology, 2012, 28(7): 499-501. |
| [9] | Liu XiaoXin, Liu YunYi. Recent advances in radical cholecystectomy treatment of gallbladder cancer[J]. Journal of Clinical Hepatology, 2012, 28(7): 496-498. |
| [10] | Yang WeiFu, Li DeChun, Yin ShanHe. Significance and expression of STAT3 in survivin primary gallbladder carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(9): 939-943. |
| [11] | Le WenJin, Ding YouMing, Yi ZuoHuiZi, Hu HaiTao, Song Yong. Risk factors of gallbladder polyps becoming malignant: a meta-analysis[J]. Journal of Clinical Hepatology, 2011, 27(9): 934-938+943. |
| [12] | Liu XiMeng. Misdiagnosis of 2 cases of gallbladder young[J]. Journal of Clinical Hepatology, 2010, 26(5): 553-553. |
| [13] | Yang LePing, Yang ZhuLin, Lan SiGen, Fu Xi, Huang JiangSheng, Luo Xin. Expression of insulin-like growth factor-binding protein-2 (IGFBP2) and matrix metalloproteinase-9 (MMP9) and its clinicopathologieal significances in benign and malignant lesions of gallbladder[J]. Journal of Clinical Hepatology, 2008, 24(6): 442-445. |
| [15] | Zhang MingWei, Zhang Jing, Zhao ZhengHong. Dentritic cell infiltration and PCNA expression in gallbladder carcinoma and their significances.[J]. Journal of Clinical Hepatology, 2002, 18(5): 288-289. |
| [16] | Gu HuaPing, Liu YanRu, Shang PeiZhong. Expression of CD44v6 and C-erbB-2 in gallbladder neoplasms and their relatonship[J]. Journal of Clinical Hepatology, 2002, 18(6): 370-371. |
| [17] | Li HaiGang, Ceng YunJie, Dong ShuKun, Lin MinLing, Wu DongXia. Expression and Significance of Cell Adhesion Molecules in Gallbladder Carcinoma[J]. Journal of Clinical Hepatology, 2001, 17(2): 114-115. |
| [18] | Gu HuaPing, Shang PeiZhong, Zhou CuiLing. Expression of CD15 and Bcl-2 in gallbladder carcinoma and their relationship[J]. Journal of Clinical Hepatology, 2001, 17(1): 57-58. |
DownLoad: